Overview

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical